Mathieu Chicard

Paris, 75005, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors.

Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors.

Journal: Cancers

Published: June 03, 2023

Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.

Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma.

Journal: JCO precision oncology

Published: January 18, 2023

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.

Journal: JCO precision oncology

Published: October 20, 2022

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies.

The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies.

Journal: Cancer discovery

Published: August 20, 2021

The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.

The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 12, 2021

Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis.

Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 18, 2021

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.

Journal: Nature communications

Published: November 19, 2020

Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study.

Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study.

Journal: Epigenetics

Published: July 15, 2020

Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.

Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.

Journal: International journal of cancer

Published: November 16, 2018

Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis.

Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis.

Journal: International journal of cancer

Published: December 11, 2017

QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction.

QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction.

Journal: Bioinformatics (Oxford, England)

Published: June 27, 2017

Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma.

Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 02, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026